30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Auxilium Pharmaceuticals LLC (AUXL)

Track

Stock chart
Ticker: AUXL Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Lurker Nancy
2 sales — total 1,102,620 USD
Sale 5 Dec 2014
Value US$3,287,116.21 | Price 166.91 | Shares 35,673
Sale 5 Dec 2014
Value US$3,012,324.10 | Price 343.05 | Shares 67,653
Sale 5 Dec 2014
Value US$4,079,511.99 | Price 364.17 | Shares 460
Sale 5 Dec 2014
Value US$1,358,704.00 | Price 33.97 | Shares 40,000
Sale 5 Dec 2014
Value US$327,953.27 | Price 33.85 | Shares 9,689
Sale 4 Dec 2014
Value US$673,452.00 | Price 33.67 | Shares 20,000
Sale 3 Dec 2014
Value US$1,700,000.00 | Price 34.00 | Shares 50,000
Sale 2 Dec 2014
Value US$645,725.88 | Price 33.75 | Shares 19,135
Sale 2 Dec 2014
Value US$8,790,808.00 | Price 33.81 | Shares 260,000
Sale 2 Dec 2014
Value US$1,701,635.00 | Price 34.03 | Shares 50,000
Sale 25 Nov 2014
Value US$808,309.88 | Price 34.03 | Shares 23,750
Sale 25 Nov 2014
Value US$137,963.71 | Price 34.05 | Shares 4,052
Sale 25 Nov 2014
Value US$107,534.18 | Price 34.13 | Shares 3,151
Sale 25 Nov 2014
Value US$360,394.45 | Price 34.12 | Shares 10,562
Sale 21 Nov 2014
Value US$4,492,411.56 | Price 33.43 | Shares 134,375
Sale 21 Nov 2014
Value US$177,517.57 | Price 33.44 | Shares 5,308
Sale 21 Nov 2014
Value US$2,325,031.29 | Price 33.50 | Shares 69,412
Sale 21 Nov 2014
Value US$214,074.85 | Price 33.50 | Shares 6,391
Sale 21 Nov 2014
Value US$167,431.50 | Price 33.49 | Shares 5,000
Sale 21 Nov 2014
Value US$122,011.01 | Price 33.45 | Shares 3,648
Sale 20 Nov 2014
Value US$455,086.17 | Price 33.18 | Shares 13,717
Sale 20 Nov 2014
Value US$4,740,206.74 | Price 33.18 | Shares 142,875
Sale 20 Nov 2014
Value US$1,351,371.88 | Price 33.16 | Shares 40,750
Sale 20 Nov 2014
Value US$238,963.08 | Price 33.18 | Shares 7,202
Sale 20 Nov 2014
Value US$1,983,870.98 | Price 33.18 | Shares 59,800
Sale 20 Nov 2014
Value US$204,253.42 | Price 32.94 | Shares 6,200
Sale 14 Mar 2014
Value US$15,484.20 | Price 29.55 | Shares 524
Sale 14 Mar 2014
Value US$26,092.65 | Price 29.55 | Shares 883
Sale 14 Mar 2014
Value US$903,437.50 | Price 29.50 | Shares 30,625
Sale 5 Mar 2014
Value US$318,477.00 | Price 31.85 | Shares 10,000
Planned sale 13 Dec 2013
Value US$6,191.00 | Price 20.50 | Shares 302
Sale 13 Dec 2013
Value US$88,150.00 | Price 20.50 | Shares 4,300
Planned sale 11 Dec 2013
Value US$1,447,450.02 | Price 20.37 | Shares 71,067
Sale 20 May 2013
Value US$30,208.80 | Price 15.10 | Shares 2,000
Planned sale 25 Jun 2012
Value US$317,155.26 | Price 25.01 | Shares 12,682
Sale 6 Jun 2012
Value US$128,535.57 | Price 22.55 | Shares 5,700
Sale 6 Jun 2012
Value US$6,765.99 | Price 22.55 | Shares 300
Buy 28 Feb 2012
Value US$194,970.00 | Price 20.10 | Shares 9,700
Buy 28 Feb 2012
Value US$6,028.20 | Price 20.09 | Shares 300
Buy 3 Nov 2011
Value US$25,024.07 | Price 15.54 | Shares 1,610
Planned sale 7 Oct 2011
Value US$75,045.84 | Price 14.23 | Shares 5,275
Sale 2 Aug 2011
Value US$703,390.69 | Price 17.25 | Shares 40,781
Sale 2 Aug 2011
Value US$17,265.25 | Price 17.25 | Shares 1,001
Sale 2 Aug 2011
Value US$8,744.74 | Price 17.25 | Shares 507
Sale 2 Aug 2011
Value US$109,714.53 | Price 17.25 | Shares 6,361
Sale 1 Aug 2011
Value US$7,114,614.32 | Price 18.04 | Shares 394,404
Sale 1 Aug 2011
Value US$4,703,319.61 | Price 18.03 | Shares 260,868
Sale 1 Aug 2011
Value US$174,580.47 | Price 18.04 | Shares 9,678
Sale 1 Aug 2011
Value US$115,388.80 | Price 18.03 | Shares 6,400
Sale 1 Aug 2011
Value US$88,426.69 | Price 18.04 | Shares 4,902
Sale 1 Aug 2011
Value US$58,469.67 | Price 18.03 | Shares 3,243
Sale 1 Aug 2011
Value US$1,109,735.09 | Price 18.04 | Shares 61,519
Sale 1 Aug 2011
Value US$733,620.36 | Price 18.03 | Shares 40,690
Planned sale 8 Jul 2011
Value US$107,100.96 | Price 20.30 | Shares 5,275
Buy 30 Mar 2011
Value US$85,963.39 | Price 21.98 | Shares 3,911
Buy 30 Mar 2011
Value US$6,791.79 | Price 21.98 | Shares 309
Buy 29 Mar 2011
Value US$1,798,670.00 | Price 21.94 | Shares 82,000
Buy 29 Mar 2011
Value US$5,499,400.00 | Price 22.00 | Shares 250,000
Buy 9 Mar 2011
Value US$12,513,765.00 | Price 22.75 | Shares 550,000
Buy 9 Mar 2011
Value US$2,695,059.50 | Price 23.44 | Shares 115,000
Buy 9 Mar 2011
Value US$2,717,344.41 | Price 23.17 | Shares 117,273
Buy 8 Mar 2011
Value US$1,331,976.25 | Price 22.81 | Shares 58,388
Buy 8 Mar 2011
Value US$43,845.39 | Price 22.51 | Shares 1,948
Buy 8 Mar 2011
Value US$1,112,299.02 | Price 22.86 | Shares 48,657
Buy 8 Mar 2011
Value US$1,972,692.68 | Price 22.88 | Shares 86,227
Buy 8 Mar 2011
Value US$253,502.88 | Price 23.05 | Shares 10,996
Buy 8 Mar 2011
Value US$36,773.75 | Price 22.81 | Shares 1,612
Buy 8 Mar 2011
Value US$1,215.43 | Price 22.51 | Shares 54
Buy 8 Mar 2011
Value US$30,700.98 | Price 22.86 | Shares 1,343
Buy 8 Mar 2011
Value US$54,449.40 | Price 22.88 | Shares 2,380
Buy 8 Mar 2011
Value US$7,008.45 | Price 23.05 | Shares 304
Planned sale 8 Mar 2011
Value US$121,501.71 | Price 23.03 | Shares 5,275
Planned sale 8 Mar 2011
Value US$121,491.74 | Price 23.01 | Shares 5,280
Planned sale 10 Jan 2011
Value US$122,723.40 | Price 23.27 | Shares 5,275
Planned sale 10 Jan 2011
Value US$122,327.04 | Price 23.17 | Shares 5,280
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-12-08 2014-12-05 S Sale Lurker Nancy Non-Executive Director
35,673 +26.8%
166.91
US$3,287,116 		35,673 +26.8% 166.91 US$3,287,116
2014-12-08 2014-12-05 S Sale Lurker Nancy Non-Executive Director
67,653 -48.8%
343.05
US$3,012,324 		67,653 -48.8% 343.05 US$3,012,324
2014-12-08 2014-12-05 S Sale MCKEE WILLIAM Non-Executive Director
460 -39.4%
364.17
US$4,079,512 		460 -39.4% 364.17 US$4,079,512
2014-12-08 2014-12-05 S Sale ADAMS ADRIAN

CEO and President

Executive Director
40,000 -15.5%
33.97
US$1,358,704 		40,000 -15.5% 33.97 US$1,358,704
2014-12-08 2014-12-05 S Sale FRIEDMAN PAUL A Non-Executive Director
9,689 -48.3%
33.85
US$327,953 		9,689 -48.3% 33.85 US$327,953
2014-12-08 2014-12-04 S Sale FRIEDMAN PAUL A Non-Executive Director
20,000 -49.9%
33.67
US$673,452 		20,000 -49.9% 33.67 US$673,452
2014-12-04 2014-12-03 S Sale FETZER OLIVER Non-Executive Director
50,000 -72.3%
34.00
US$1,700,000 		50,000 -72.3% 34.00 US$1,700,000
2014-12-04 2014-12-02 S Sale CLASSON ROLF A Non-Executive Director
19,135 -65.7%
33.75
US$645,726 		19,135 -65.7% 33.75 US$645,726
2014-12-04 2014-12-02 S Sale CLASSON ROLF A Non-Executive Director
260,000 -89.9%
33.81
US$8,790,808 		260,000 -89.9% 33.81 US$8,790,808
2014-12-04 2014-12-02 S Sale FETZER OLIVER Non-Executive Director
50,000 -72.3%
34.03
US$1,701,635 		50,000 -72.3% 34.03 US$1,701,635
2014-11-26 2014-11-25 S Sale JOBES ELIZABETH VARKI

Chief Compliance Officer

Officer
23,750 -63.3%
34.03
US$808,310 		23,750 -63.3% 34.03 US$808,310
2014-11-26 2014-11-25 S Sale JOBES ELIZABETH VARKI

Chief Compliance Officer

Officer
4,052 -9.7%
34.05
US$137,964 		4,052 -9.7% 34.05 US$137,964
2014-11-26 2014-11-25 S Sale Tursi James Patrick

Chief Medical Officer

Officer
3,151 -9.0%
34.13
US$107,534 		3,151 -9.0% 34.13 US$107,534
2014-11-26 2014-11-25 S Sale Tursi James Patrick

Chief Medical Officer

Officer
10,562 -23.2%
34.12
US$360,394 		10,562 -23.2% 34.12 US$360,394
2014-11-24 2014-11-21 S Sale KOVEN ANDREW I

EVP, CAO, GC and Secretary

Officer
134,375 -77.6%
33.43
US$4,492,412 		134,375 -77.6% 33.43 US$4,492,412
2014-11-24 2014-11-21 S Sale KOVEN ANDREW I

EVP, CAO, GC and Secretary

Officer
5,308 -3.0%
33.44
US$177,518 		5,308 -3.0% 33.44 US$177,518
2014-11-24 2014-11-21 S Sale Armstrong Jennifer Lou

Senior Vice President, HR

Officer
69,412 -82.4%
33.50
US$2,325,031 		69,412 -82.4% 33.50 US$2,325,031
2014-11-24 2014-11-21 S Sale Armstrong Jennifer Lou

Senior Vice President, HR

Officer
6,391 -7.0%
33.50
US$214,075 		6,391 -7.0% 33.50 US$214,075
2014-11-24 2014-11-21 S Sale Tursi James Patrick

Chief Medical Officer

Officer
5,000 -12.5%
33.49
US$167,432 		5,000 -12.5% 33.49 US$167,432
2014-11-24 2014-11-21 S Sale Tursi James Patrick

Chief Medical Officer

Officer
3,648 -8.3%
33.45
US$122,011 		3,648 -8.3% 33.45 US$122,011
2014-11-24 2014-11-20 S Sale WILLS ALAN

EVP, Corporate Development

Officer
13,717 -30.9%
33.18
US$455,086 		13,717 -30.9% 33.18 US$455,086
2014-11-24 2014-11-20 S Sale WILLS ALAN

EVP, Corporate Development

Officer
142,875 -76.3%
33.18
US$4,740,207 		142,875 -76.3% 33.18 US$4,740,207
2014-11-24 2014-11-20 S Sale Glickman Mark A

EVP - Sales and Marketing

Officer
40,750 -59.3%
33.16
US$1,351,372 		40,750 -59.3% 33.16 US$1,351,372
2014-11-24 2014-11-20 S Sale Glickman Mark A

EVP - Sales and Marketing

Officer
7,202 -9.5%
33.18
US$238,963 		7,202 -9.5% 33.18 US$238,963
2014-11-24 2014-11-20 S Sale Tursi James Patrick

Chief Medical Officer

Officer
59,800 -57.8%
33.18
US$1,983,871 		59,800 -57.8% 33.18 US$1,983,871
2014-11-24 2014-11-20 S Sale Tursi James Patrick

Chief Medical Officer

Officer
6,200 -5.7%
32.94
US$204,253 		6,200 -5.7% 32.94 US$204,253
2014-03-17 2014-03-14 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
524 -8.3%
29.55
US$15,484 		524 -8.3% 29.55 US$15,484
2014-03-17 2014-03-14 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
883 -12.3%
29.55
US$26,093 		883 -12.3% 29.55 US$26,093
2014-03-17 2014-03-14 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
30,625 -57.4%
29.50
US$903,438 		30,625 -57.4% 29.50 US$903,438
2014-03-06 2014-03-05 S Sale CLASSON ROLF A Non-Executive Director
10,000 -30.4%
31.85
US$318,477 		10,000 -30.4% 31.85 US$318,477
2013-12-16 2013-12-13 PlS Planned sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
302 -6.9%
20.50
US$6,191 		302 -6.9% 20.50 US$6,191
2013-12-16 2013-12-13 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
4,300 -49.6%
20.50
US$88,150 		4,300 -49.6% 20.50 US$88,150
2013-12-12 2013-12-11 PlS Planned sale Fickenscher James E

Chief Financial Officer

Officer
71,067 -61.2%
20.37
US$1,447,450 		71,067 -61.2% 20.37 US$1,447,450
2013-05-22 2013-05-20 S Sale MCKEE WILLIAM Non-Executive Director
2,000 -20.0%
15.10
US$30,209 		2,000 -20.0% 15.10 US$30,209
2012-06-26 2012-06-25 PlS Planned sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
12,682 -73.9%
25.01
US$317,155 		12,682 -73.9% 25.01 US$317,155
2012-06-08 2012-06-06 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
5,700 -73.8%
22.55
US$128,536 		5,700 -73.8% 22.55 US$128,536
2012-06-08 2012-06-06 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
300 -3.7%
22.55
US$6,766 		300 -3.7% 22.55 US$6,766
2012-03-01 2012-02-28 B Purchase Brandt Peter C. Non-Executive Director
9,700 +3233.3%
20.10
US$194,970 		9,700 +3233.3% 20.10 US$194,970
2012-03-01 2012-02-28 B Purchase Brandt Peter C. Non-Executive Director
300 +inf%
20.09
US$6,028 		300 +inf% 20.09 US$6,028
2011-11-07 2011-11-03 B Purchase Fickenscher James E

Chief Financial Officer

Officer
1,610 +6.4%
15.54
US$25,024 		1,610 +6.4% 15.54 US$25,024
2011-10-11 2011-10-07 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,275 -27.9%
14.23
US$75,046 		5,275 -27.9% 14.23 US$75,046
2011-08-03 2011-08-02 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
40,781 -0.7%
17.25
US$703,391 		40,781 -0.7% 17.25 US$703,391
2011-08-03 2011-08-02 S Sale 14159 capital (GP), LLC Large shareholder
1,001 -0.7%
17.25
US$17,265 		1,001 -0.7% 17.25 US$17,265
2011-08-03 2011-08-02 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
507 -0.7%
17.25
US$8,745 		507 -0.7% 17.25 US$8,745
2011-08-03 2011-08-02 S Sale Baker Biotech Capital (GP), LLC Large shareholder
6,361 -0.7%
17.25
US$109,715 		6,361 -0.7% 17.25 US$109,715
2011-08-03 2011-08-01 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
394,404 -6.7%
18.04
US$7,114,614 		394,404 -6.7% 18.04 US$7,114,614
2011-08-03 2011-08-01 S Sale 14159 capital (GP), LLC Large shareholder
9,678 -6.7%
18.04
US$174,580 		9,678 -6.7% 18.04 US$174,580
2011-08-03 2011-08-01 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
4,902 -6.7%
18.04
US$88,427 		4,902 -6.7% 18.04 US$88,427
2011-08-03 2011-08-01 S Sale Baker Biotech Capital (GP), LLC Large shareholder
61,519 -6.7%
18.04
US$1,109,735 		61,519 -6.7% 18.04 US$1,109,735
2011-08-03 2011-08-01 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
260,868 -4.3%
18.03
US$4,703,320 		260,868 -4.3% 18.03 US$4,703,320
2011-08-03 2011-08-01 S Sale 14159 capital (GP), LLC Large shareholder
6,400 -4.3%
18.03
US$115,389 		6,400 -4.3% 18.03 US$115,389
2011-08-03 2011-08-01 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
3,243 -4.3%
18.03
US$58,470 		3,243 -4.3% 18.03 US$58,470
2011-08-03 2011-08-01 S Sale Baker Biotech Capital (GP), LLC Large shareholder
40,690 -4.3%
18.03
US$733,620 		40,690 -4.3% 18.03 US$733,620
2011-07-12 2011-07-08 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,275 -27.9%
20.30
US$107,101 		5,275 -27.9% 20.30 US$107,101
2011-03-31 2011-03-30 B Purchase 14159 capital (GP), LLC Large shareholder
3,911 +2.7%
21.98
US$85,963 		3,911 +2.7% 21.98 US$85,963
2011-03-31 2011-03-30 B Purchase Baker Bros. Capital (GP), LLC Large shareholder
309 +4.6%
21.98
US$6,792 		309 +4.6% 21.98 US$6,792
2011-03-31 2011-03-29 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
82,000 +1.4%
21.94
US$1,798,670 		82,000 +1.4% 21.94 US$1,798,670
2011-03-31 2011-03-29 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
250,000 +4.3%
22.00
US$5,499,400 		250,000 +4.3% 22.00 US$5,499,400
2011-03-10 2011-03-09 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
550,000 +10.5%
22.75
US$12,513,765 		550,000 +10.5% 22.75 US$12,513,765
2011-03-10 2011-03-09 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
115,000 +2.3%
23.44
US$2,695,060 		115,000 +2.3% 23.44 US$2,695,060
2011-03-10 2011-03-09 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
117,273 +2.3%
23.17
US$2,717,344 		117,273 +2.3% 23.17 US$2,717,344
2011-03-10 2011-03-08 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
58,388 +1.2%
22.81
US$1,331,976 		58,388 +1.2% 22.81 US$1,331,976
2011-03-10 2011-03-08 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
1,948 +0.0%
22.51
US$43,845 		1,948 +0.0% 22.51 US$43,845
2011-03-10 2011-03-08 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
48,657 +1.0%
22.86
US$1,112,299 		48,657 +1.0% 22.86 US$1,112,299
2011-03-10 2011-03-08 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
86,227 +1.8%
22.88
US$1,972,693 		86,227 +1.8% 22.88 US$1,972,693
2011-03-10 2011-03-08 B Purchase 14159 capital (GP), LLC Large shareholder
1,612 +1.1%
22.81
US$36,774 		1,612 +1.1% 22.81 US$36,774
2011-03-10 2011-03-08 B Purchase 14159 capital (GP), LLC Large shareholder
54 +0.0%
22.51
US$1,215 		54 +0.0% 22.51 US$1,215
2011-03-10 2011-03-08 B Purchase 14159 capital (GP), LLC Large shareholder
1,343 +0.9%
22.86
US$30,701 		1,343 +0.9% 22.86 US$30,701
2011-03-10 2011-03-08 B Purchase 14159 capital (GP), LLC Large shareholder
2,380 +1.7%
22.88
US$54,449 		2,380 +1.7% 22.88 US$54,449
2011-03-10 2011-03-08 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
10,996 +0.2%
23.05
US$253,503 		10,996 +0.2% 23.05 US$253,503
2011-03-10 2011-03-08 B Purchase 14159 capital (GP), LLC Large shareholder
304 +0.2%
23.05
US$7,008 		304 +0.2% 23.05 US$7,008
2011-03-09 2011-03-08 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,275 -24.7%
23.03
US$121,502 		5,275 -24.7% 23.03 US$121,502
2011-03-09 2011-03-08 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,280 -24.7%
23.01
US$121,492 		5,280 -24.7% 23.01 US$121,492
2011-01-12 2011-01-10 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,275 -24.7%
23.27
US$122,723 		5,275 -24.7% 23.27 US$122,723
2011-01-12 2011-01-10 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,280 -24.7%
23.17
US$122,327 		5,280 -24.7% 23.17 US$122,327
Explore more

More insider trading research around Auxilium Pharmaceuticals LLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America